Navigation Links
Insmed Announces Financial Results For Second Quarter And Six-months Ended June 30, 2012

2-42Net loss

(9,696)(10,017)(16,541)(16,912)Accretion of beneficial conversion charge

---(9,175)Net loss  attributable to common


$   (9,696)$ (10,017)$ (16,541)$ (26,087)Basic and diluted net loss attributable to

common stockholders per common share

(1.19)Comprehensive loss

$   (9,726)$   (9,714)$ (16,355)$ (16,788)Weighted average basic and diluted common shares outstanding

24,87524,83024,86721,838 INSMED INCORPORATEDConsolidated Statements of Cash Flows (Unaudited)(in thousands) Six Months Ended June 30,20122011Operating activitiesNet loss$
(16,912)Adjustments to reconcile net (loss) income to net cash (used in)provided by operating activities:Depreciation and amortization274154Stock based compensation expense1,013652Gain on sale of asset, net(5)-Changes in operating assets and liabilities:  Accounts receivable757168  Prepaid expenses and other assets(263)(364)  Accounts payable864471  Accrued expenses1,07819  Accrued lease expenses(129)0  Accrued compensation54(113)  Deferred revenue-(207)Net cash used in operating activities(12,898)(16,132)Investing activities  Purchase of fixed assets(95)(68)  Proceeds from sale of asset5-  Sales of short-term investments 17,05116,769  Purchases of short-term investments -(1,463)Net cash provided by investing activities16,96115,238Financing activitiesPayments on capital lease obligations(62)(42)Proceeds from issuance of debt net of issuance and financing costs9,726-Proceeds from issuance of common stock-32Net cash provided by (used in) financing activities9,664(10)Increase in cash and cash equivalents13,727(904)Cash and cash equivalents at beginning of period14,84810,743Cash and cash equivalents at end of period$
9,839Supplemental disclosures of cash flow informationCash paid for interest$

SOURCE Insmed Incorporated
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. Insmed Secures $20 Million Loan Agreement With Hercules Technology Growth Capital
2. Insmed Incorporated Provides Corporate Update
3. Organogenesis Announces Annual College Scholarship Award Winner
4. Bion Announces Approval of New Canadian Patent
5. PDL BioPharma Announces Second Quarter 2012 Financial Results
6. BioPower Operations Corporation Announces that FTZ Exchange Signs Strategic Alliance with Capacity 360, LLC and Tom Settineri
7. Accuray Announces First CyberKnife System in South America
8. Haemonetics Reports First Quarter Fiscal 2013 Results, Completes Acquisition of Palls Transfusion Medicine Business, Affirms Fiscal 2013 Earnings Guidance, Provides Preliminary Outlook for Fiscal 2014 and Announces Share Repurchase
9. Karyopharm Therapeutics announces the Publication of Two Preclinical Studies on the Activity of Selective Inhibitors of Nuclear Export (SINE) in Acute Myeloblastic Leukemia (AML)
10. AMRI Announces Second Quarter 2012 Results
11. MAP Pharmaceuticals, Inc. Announces Proposed Public Offering of Common Stock
Post Your Comments:
(Date:1/15/2014)... 2013 was a banner year of continued ... saw continued independent research led by the team at ... $1 million grant from the Susanne Marcus Collins Foundation, ... peer reviewed journal, Amy Grant highlighted Brainwave Optimization® in ...
(Date:1/15/2014)... TAIPEI , Jan. 15, 2014 TaiGen Biotechnology ... an exclusive agreement with R-Pharm, a leading Russian pharmaceutical ... in the Russian Federation , ... Commonwealth Independent States (CIS). Nemonoxacin is a novel antibiotic for ...
(Date:1/14/2014)... Diego, CA (PRWEB) January 14, 2014 ... on the products of cells grown under simulated embryonic ... international license agreement with Suneva Medical, Inc. for physician-dispensed ... (CCM). , This agreement is an amendment ...
(Date:1/14/2014)... (PRWEB) January 14, 2014 EquitiesIQ, a ... Inc. (OTCQB: ALQA). Alliqua is an emerging biomedical company ... the wound care market. , Free report download: ... with a seasoned management team and Board, which launched ...
Breaking Biology Technology:Dynamic Innovative Technology Showcased at Scottsdale Company’s Open House 2Dynamic Innovative Technology Showcased at Scottsdale Company’s Open House 3TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 2TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 3TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 4Histogen and Suneva Medical Expand License for Cell Conditioned Media-based Aesthetic Products Internationally 2Histogen and Suneva Medical Expand License for Cell Conditioned Media-based Aesthetic Products Internationally 3EquitiesIQ Initiates Coverage of Alliqua, Inc. 2EquitiesIQ Initiates Coverage of Alliqua, Inc. 3
... ("CTI") (Nasdaq and MTA: CTIC) announced today that it has been ... posted by Russell Investments on June 29, 2009 on ... and global equity indexes on an annual basis. , ... largest U.S. stocks as of the last trading day of May, ...
... Corp. (Nasdaq: BSTC ), a biopharmaceutical company developing ... added to the Russell 3000 and Russell 2000 Indexes effective ... 2009. The Russell family of U.S. indexes is reconstituted annually ... investable U.S. equity market. , , The Russell 3000 ...
... Micromet, Inc. (Nasdaq: MITI ), a ... of cancer, inflammation and autoimmune diseases, today announced that ... part of the annual reconstitution of the Russell indexes, ... "Investors recognize the Russell 3000 as an established benchmark ...
Cached Biology Technology:Cell Therapeutics Added to Russell 3000(R), Russell 2000(R) and Russell Global(R) Indexes 2Cell Therapeutics Added to Russell 3000(R), Russell 2000(R) and Russell Global(R) Indexes 3BioSpecifics Technologies Corp. Added to Russell 3000 and Russell 2000 Indexes 2Micromet Added to Russell 3000 Index 2Micromet Added to Russell 3000 Index 3Micromet Added to Russell 3000 Index 4
(Date:7/9/2014)... fungal pathogens pose a greater threat to biodiversity ... of amphibians, bats, corals, bees and snakes. New ... in the prestigious journal Nature reveals ... to a deadly chytrid fungus implicated in global ... important because it is the basis of vaccination ...
(Date:7/9/2014)... Guelph scientist that involved fitting bumblebees with tiny ... neonicotinoid pesticide hampers bees, ability to forage for ... professor in Guelph,s School of Environmental Sciences, and ... July 9 in the British Ecological Society,s journal ... how long-term pesticide exposure affects individual bees, day-to-day ...
(Date:7/9/2014)... fever but often can be defeated with antibiotics and ... beat. Now, scientists have built a new weapon against such ... the journal ACS Applied Materials & Interfaces , their ... of them than medicine alone. , David Leong, Jianping Xie ... wait, undetectable in the human body or in places that ...
Breaking Biology News(10 mins):USF study: Amphibians can acquire resistance to deadly fungus 2Bee foraging chronically impaired by pesticide exposure: Study 2
... why a tuberculosis vaccine is not as effective for some ... not work as well for some as they do for ... issue of the Journal of Leukocyte Biology ( ... common environmental bacterium found in soil and water, can decrease ...
... State University have solved a long-standing conundrum about ... way into limestone, sand grains, mussel shells, coral ... According to the lead investigator, ASU professor ... what is "at the heart of an erosive ...
... New Rochelle, NY, November 30, 2010Access to quality reproductive ... aspect of a woman,s human rights, freedom, equity, and ... on Global Women,s Reproductive Health in the current issue ... by Mary Ann Liebert, Inc., explores the compelling medical, ...
Cached Biology News:Blame the environment: Why vaccines may be ineffective for some people 2Mystery dissolves with calcium pump discovery 2Mystery dissolves with calcium pump discovery 3Ensuring the rights of women worldwide to reproductive health care 2
One-step, microplate or cuvet, colorimetric, detection range 0.78 ug/dL to 65 ug/dL Zn in serum, plasma, urine, saliva etc. Procedure: 10 min....
Zebrafish Ephrin-B2 Biotinylated Affinity Purified PAb...
... Customer Peptide Synthesis , Containing one Phospho-Amino Acid ... returned to customer conjugation of peptide to KLH protein , ... 102 days/each , Pre-immune bleed x1 /each ... Test bleed (app. 5 ml) x1 /each ...
The Varian 4000 GC/MS system offers three easily switchable ionization configurations: internal ionization (II), external ionization (EI) or hybrid chemical ionization (CI)...
Biology Products: